Cargando…
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy
BACKGROUND: Real-world data on early treatment of coronavirus disease 2019 (COVID-19) outpatients with newly approved therapies are sparse. AIM: To explore the pattern of use of monoclonal antibodies (mAbs)/antiviral therapies approved for early COVID-19 treatment in non-hospitalized patients from E...
Autores principales: | Ciccimarra, Francesco, Luxi, Nicoletta, Bellitto, Chiara, L’ Abbate, Luca, De Nardo, Pasquale, Savoldi, Alessia, Yeomans, Alison, Molokhia, Mariam, Tacconelli, Evelina, Trifirò, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163563/ https://www.ncbi.nlm.nih.gov/pubmed/37148526 http://dx.doi.org/10.1007/s40259-023-00601-w |
Ejemplares similares
-
Personalized infection prevention and control: a concept whose time has arrived
por: Savoldi, Alessia, et al.
Publicado: (2023) -
The future role of the GP Quality and Outcomes Framework in England
por: Majeed, Azeem, et al.
Publicado: (2023) -
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
por: Gupta, Akshita, et al.
Publicado: (2023) -
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
por: Mazzaferri, Fulvia, et al.
Publicado: (2022) -
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study
por: Savoldi, Alessia, et al.
Publicado: (2022)